Michael Perry - Dec 22, 2021 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Role
Chief Executive Officer, Director
Signature
/s/ Donna Shiroma, by power of attorney
Stock symbol
RCEL
Transactions as of
Dec 22, 2021
Transactions value $
$0
Form type
4
Date filed
12/27/2021, 03:30 PM
Previous filing
Sep 7, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +23.8K +10.29% 255K Dec 22, 2021 Direct F1, F2, F3, F4
transaction RCEL Common Stock Award +23.8K +9.33% 279K Dec 22, 2021 Direct F2, F3, F5
transaction RCEL Common Stock Award +23.8K +8.54% 303K Dec 22, 2021 Direct F2, F3, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +13.8K $0.00 13.8K Dec 22, 2021 Common Stock 13.8K $12.18 Direct F7
transaction RCEL Stock Options (Right to Buy) Award $0 +13.8K $0.00 13.8K Dec 22, 2021 Common Stock 13.8K $12.18 Direct F8
transaction RCEL Stock Options (Right to Buy) Award $0 +13.8K $0.00 13.8K Dec 22, 2021 Common Stock 13.8K $12.18 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in four equal annual installments on December 14, 2022, 2023, 2024 and 2025.
F2 Includes unvested RSUs.
F3 Includes 634,602 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of Common Stock and have all the rights and privileges of Common Stock. The Reporting Person holds 634,602 CDIs, which translate into 126,920 of the shares of Common Stock set forth above.
F4 Amount in column 5 reflects a decrease of 6,267 shares of Common Stock from the total reported in the Reporting Person's Form 4 filed on September 7, 2021 (the "Prior Form 4") following the finalization of a division of property with the Reporting Person's former spouse pursuant to a property settlement agreement. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse following a separation occurring after the Prior Form 4.
F5 Represents an award of RSUs with vesting conditioned on the market price of the Issuer's Common Stock reaching $24.36 (based upon a 10-day volume-weighted average price) by June 30, 2023. Upon the condition being met, a portion of the RSUs will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.
F6 Represents an award of RSUs with vesting conditioned on the market capitalizaton of the Issuer being $1.25 billion or greater for 30 consecutive calendar days on or before December 31, 2024. Upon the condition being met, a portion of the RSUs will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.
F7 These Stock Options vest in four equal annual installments on December 14, 2022, 2023, 2024 and 2025.
F8 These vesting of these Stock Options is conditioned on on the market price of the Issuer's Common Stock reaching $24.36 (based upon a 10-day volume-weighted average price) by June 30, 2023. Upon the condition being met, a portion of the Stock Options will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.
F9 The vesting of these Stock Options is conditioned on the market capitalizaton of the Issuer being $1.25 billion or greater for 30 consecutive calendar days on or before December 31, 2024. Upon the condition being met, a portion of the Stock Options will vest immediately and the remainder will vest in a number of annual installments depending on the year in which the condition is met.